Mammalian antimicrobial peptide influences control of cutaneous Leishmania infection.
about
Efficacy of synthetic peptides RP-1 and AA-RP-1 against Leishmania species in vitro and in vivoCopy number variation of individual cattle genomes using next-generation sequencing.Genome-wide copy number variation (CNV) detection in Nelore cattle reveals highly frequent variants in genome regions harboring QTLs affecting production traits.Screening, Expression, Purification and Functional Characterization of Novel Antimicrobial Peptide Genes from Hermetia illucens (L.).Cytokines and microbicidal molecules regulated by IL-32 in THP-1-derived human macrophages infected with New World Leishmania species.Epithelial antimicrobial defence of the skin and intestine.Protective role of the neuropeptide urocortin II against experimental sepsis and leishmaniasis by direct killing of pathogens.Antimicrobial peptides: old molecules with new ideas.Modes of action of Leishmanicidal antimicrobial peptides.Nanoparticles as multifunctional devices for the topical treatment of cutaneous leishmaniasis.Whole genome sequencing of Gir cattle for identifying polymorphisms and loci under selection.Secreted trypanosome cyclophilin inactivates lytic insect defense peptides and induces parasite calcineurin activation and infectivityBacterial subversion of cAMP signalling inhibits cathelicidin expression, which is required for innate resistance to Mycobacterium tuberculosis.Methods for In Vivo/Ex Vivo Analysis of Antimicrobial Peptides in Bacterial Keratitis: siRNA Knockdown, Colony Counts, Myeloperoxidase, Immunostaining, and RT-PCR Assays.Multiple immune-modulatory functions of cathelicidin host defense peptides.Design of protease-resistant pexiganan enhances antileishmanial activity.
P2860
Q35689355-B39659B2-A574-4D7E-AFE2-945BF8CB21F5Q35864751-72E66745-509D-4E7A-AE56-865393D418D6Q36051142-4224B78D-3E44-4F1E-8EB5-F70E0A4299EEQ36240380-8D6889E4-D1EB-4976-A60F-14A850E8300DQ36291428-5CBB83B8-85F5-47C1-9D71-12776E0424ADQ36584725-46ED7B0A-ED67-483A-BFCC-B744A7700608Q37635671-847B228B-05A5-42DA-93C6-2A3EA3F97E6EQ37967109-E8800DAC-B9F9-452B-9C7D-850E8EDE8557Q38041188-7226CF95-7DAD-4A8F-B608-A39131F0E163Q38195310-2FF8158B-E429-4646-A95B-DE1A3F7E07F2Q39178693-848BCADE-6AF2-4009-8E07-A34357EB256FQ39198765-5EAE0A38-847E-4D1D-9875-5DFA5F3B35F6Q40367916-6136F0E8-43B3-41BE-8EA5-9BA0B47EE02BQ40396065-DC8D3C75-AB0D-449E-9384-409C96C591E6Q42169474-9445A62F-186D-4BF6-8F03-1C6481F531AAQ45374298-2B0B1B61-0F32-4DD6-AD0C-E9C5C6D7B182
P2860
Mammalian antimicrobial peptide influences control of cutaneous Leishmania infection.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Mammalian antimicrobial peptide influences control of cutaneous Leishmania infection.
@en
Mammalian antimicrobial peptide influences control of cutaneous Leishmania infection.
@nl
type
label
Mammalian antimicrobial peptide influences control of cutaneous Leishmania infection.
@en
Mammalian antimicrobial peptide influences control of cutaneous Leishmania infection.
@nl
prefLabel
Mammalian antimicrobial peptide influences control of cutaneous Leishmania infection.
@en
Mammalian antimicrobial peptide influences control of cutaneous Leishmania infection.
@nl
P2093
P2860
P1476
Mammalian antimicrobial peptide influences control of cutaneous Leishmania infection.
@en
P2093
Abhay R Satoskar
Bradford S McGwire
Joseph Barbi
Manjusha M Kulkarni
Richard L Gallo
W Robert McMaster
P2860
P304
P356
10.1111/J.1462-5822.2011.01589.X
P577
2011-04-28T00:00:00Z